Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women

Risk factors for breast carcinoma in situ and invasive breast cancer were compared using data from 61,844 women (61% post-menopausal) with no prior breast cancer and at least one screening mammogram between April 1, 1996 and June 30, 2001. The women were followed until a subsequent mammogram before July 1, 2001, or a benign biopsy or breast cancer diagnosis before June 30, 2002. A total of 1,191 breast cancers (300 in situ and 891 invasive) were diagnosed during an average follow-up of 3.1 years. Multivariate Cox regression models were used to estimate the relative risks (RR) of in situ and invasive cancer associated with family history of breast cancer, age at first childbirth or nulliparity, post-menopausal hormone use, body mass index (BMI), and mammographic breast density. Separate analyses were done for pre- and post-menopausal women. BMI was unrelated to risk of in situ cancer regardless of menopausal status, but was associated with an increased risk of invasive cancer in post-menopausal women (RR = 1.9 for BMI ≥ 30 vs. BMI < 22, 95% confidence interval 1.4–2.5). Later childbearing and nulliparity were more strongly associated with in situ than invasive cancer in pre-menopausal women. Post-menopausal hormone use was more strongly associated with invasive disease. RR associated with family history and breast density were similar for in situ cancer and invasive cancer. Results indicating that BMI is related to post-menopausal invasive cancers but unrelated to in situ cancers are consistent with the hypothesis that concomitants of obesity activate proliferation.

[1]  W. Dupont,et al.  The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up , 2005, Cancer.

[2]  B. Geller,et al.  A prospective study of breast cancer risk using routine mammographic breast density measurements. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  C. Key,et al.  The frequency of ipsilateral second tumors after breast‐conserving surgery for DCIS , 2005, Cancer.

[4]  B. Hoffman,et al.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P L Remington,et al.  Risk factors for carcinoma in situ of the breast. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  C. Swanson,et al.  Body weight: estimation of risk for breast and endometrial cancers. , 1996, The American journal of clinical nutrition.

[7]  S. Tretli Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway , 1989, International journal of cancer.

[8]  K. Kerlikowske,et al.  Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.

[9]  L. Kolonel,et al.  The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort , 2006, Breast Cancer Research.

[10]  S. Loi,et al.  Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  A. Morrison,et al.  Height and weight, mammographic features of breast tissue, and breast cancer risk. , 1984, American journal of epidemiology.

[12]  E A Sickles,et al.  Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. , 1997, Journal of the National Cancer Institute.

[13]  R. Senie,et al.  Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival , 1992, Annals of Internal Medicine.

[14]  P. Langenberg,et al.  Body mass and stage of breast cancer at diagnosis , 2002, International journal of cancer.

[15]  M. Longnecker,et al.  Risk factors for in situ breast cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  P. Wingo,et al.  Body Mass and Mortality After Breast Cancer Diagnosis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[17]  C. la Vecchia,et al.  Invasive breast cancer following ductal and lobular carcinoma in situ of the breast , 2005, International journal of cancer.

[18]  James J Dignam,et al.  Mammographic density and breast cancer after ductal carcinoma in situ. , 2004, Journal of the National Cancer Institute.

[19]  D. Brogan,et al.  Epidemiology of in situ and invasive breast cancer in women aged under 45. , 1996, British Journal of Cancer.

[20]  A. Schatzkin,et al.  Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. , 1996, American journal of epidemiology.

[21]  E. Sickles,et al.  Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. , 2000, AJR. American journal of roentgenology.

[22]  B. Stoll Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  B. Stoll Adiposity as a risk determinant for postmenopausal breast cancer , 2000, International Journal of Obesity.

[24]  M. Press,et al.  Body weight correlates with mortality in early-stage breast cancer. , 2004, Archives of surgery.